Precision Biosciences (DTIL) Cash from Investing Activities Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 30.54% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 45.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.93% |
| Dec 31, 2025 | 19.88% |
| Sep 30, 2025 | 26.32% |
| Jun 30, 2025 | 75.12% |
| Mar 31, 2025 | 27.32% |
| Dec 31, 2024 | 59.91% |
| Sep 30, 2024 | 64.92% |
| Jun 30, 2024 | 74.51% |
| Mar 31, 2024 | 71.52% |
| Dec 31, 2023 | 26.79% |
| Sep 30, 2023 | 109.72% |
| Jun 30, 2023 | 16.05% |
| Mar 31, 2023 | 13.21% |
| Dec 31, 2022 | 51.47% |
| Sep 30, 2022 | 43.10% |
| Jun 30, 2022 | 54.25% |
| Mar 31, 2022 | 45.60% |
| Dec 31, 2021 | 46.58% |
| Sep 30, 2021 | 28.43% |
| Jun 30, 2021 | -14.43% |
| Mar 31, 2021 | -22.04% |